← Evidence map

ArticleOncoimmunology2013

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR

Nathalie Chaput et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23525357